Early bird registration is open and closes May 2025. Register now

Improving the quality of our lives through state-of-the-art R&D capabilities.

Life science, with outstanding R&D competence and new drugs that have been approved by USFDA for the first time in Korea, is LG Chem’s new growth engine in the mid to long term. We are aggressively making inroads in overseas markets and expanding pipelines for new drugs through constant investment and reinforcing R&D, with aspirations to become one of the top global pharmaceutical companies.

Share

Key dates

Registrations
Abstracts

More Partners / Exhibitors

Meeting Place Fukuoka

FCVB

Eisai

Johnson & Johnson Innovative Medicine Korea

Johnson & Johnson Innovative Medicine Korea

Celltrion

Celltrion

AbbVie

Viatris